IN8bio, Inc. (INAB) Q1 2022 Earnings Call

Investor webinar replay

Replay transcript excerpt

great thank you everybody um thank you everybody here who are here in washington dc for the asgct conference it's exciting to be in person again and everybody online on the webcast we're glad that you could attend today my name is william ho i am the president and co-founder of innate bio we are one of the leading companies focused on the development of gamma delta t cells and it's a really exciting time um very quickly Very quickly, I want to make some introductions to some of the team members that are here today. Myself, I've been in biotech for over 20 years across most areas of the business, but we're really happy to have Dr. Larry Lam, our scientific co-founder, really one of the world's best experts in the translational research around gamma delta T cells. He's been working in cell therapy and manufacturing for almost 30 years. We have Pat McCall, our chief financial officer, who will be with us today. He is a CPA by training, joined us from Turnstone Biologics. And Trishna Goswami, our chief medical officer, hematologist, oncologist by training in her early years after her training. And her practice, she was at Metimmune, AstraZeneca, working on many of the checkpoint inhibitors, and most recently joined us from Gilead, where she joined from Immunomedics. She was actually involved in the approval of Chodolvi in bladder cancer and in triple negative breast. And finally, Kate Rocklin on our team is our chief operating officer, an entrepreneur and actually really well trained in oncology, was trained at Weill Cornell, did much of that training at Memorial Sloan Kettering and really fantastic in making sure everything moves forward for us. Today, we're happy to have two guests as well who will speak. Dieter Kablitz joins us from the University of Kiel. Both of the...